carteol monodose 1 % eye drops sol. single-dose cont.
viatris bv-srl - carteolol hydrochloride 10 mg/ml - eye drops, solution - 1 % - carteolol hydrochloride 10 mg/ml - carteolol
carteol monodose 2 % eye drops sol. single-dose cont.
viatris bv-srl - carteolol hydrochloride 20 mg/ml - eye drops, solution - 2 % - carteolol hydrochloride 20 mg/ml - carteolol
arteoptic la 2 % eye drops, prolonged-release
orifarm - carteolol hydrochloride - eye drops, prolonged-release - 2 % - carteolol hydrochloride 20 mg/ml - carteolol
teoptic 2% eye drops
thea pharmaceuticals ltd - carteolol hydrochloride - eye drops - 20mg/1ml
ocupress- carteolol hydrochloride solution
novartis ophthalmics - carteolol hydrochloride (unii: 4797w6i0t4) (carteolol - unii:8nf31401xg) - solution - ocupress ophthalmic solution, 1%, has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. it may be used alone or in combination with other intraocular pressure lowering medications. ocupress ophthalmic solution is contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of this product.
fortinol la 1 %w/v eye drops prolonged rel.
chauvin pharmaceuticals limited - carteolol hydrochloride - eye drops prolonged rel. - 1 %w/v
fortinol la 2 %w/v eye drops prolonged rel.
chauvin pharmaceuticals limited - carteolol hydrochloride - eye drops prolonged rel. - 2 %w/v
teoptic 1 %w/v eye drops solution
novartis pharmaceuticals uk ltd - carteolol hydrochloride - eye drops solution - 1 %w/v
teoptic 2 %w/v eye drops solution
novartis pharmaceuticals uk ltd - carteolol hydrochloride - eye drops solution - 2 %w/v
teoptic 1% eye drops
thea pharmaceuticals ltd - carteolol hydrochloride - eye drops - 10mg/1ml